Skip to main content
. Author manuscript; available in PMC: 2017 Jan 20.
Published in final edited form as: Anticancer Res. 2014 Jul;34(7):3357–3363.

Figure 2.

Figure 2

Inhibitory effect of Lipitor and Celebrex alone or in combination on NF- B activation in VCaP prostate cancer cells. VCaP/N cells were seeded at a density of 0.2×105 cells/ml of medium in 12-well plates and incubated for 24 h. The cells were then treated with Lipitor (10 μM) alone or in combination with Celebrex (10 μM) for 24 h. The NF- B transcriptional activity was measured by a luciferase activity assay. Differences in the NF- B transcriptional activity between the combination group and single agent-treated group were analyzed by ANOVA with the Tukey-Kramer multiple comparison test.*p<0.001 as compared to Lipitor or Celebrex alone.